Armistice Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20,000,000
| Closed | -$19.2M | – | 302 |
|
|
2023
Q2 | $19.2M | Buy |
20,000,000
+3,300,000
| +20% | +$3.26M | 0.28% | 69 |
|
|
2023
Q1 | $12.5M | Sell |
16,700,000
-300,000
| -2% | -$219K | 0.18% | 82 |
|
|
2022
Q4 | $6.26M | Buy |
17,000,000
+324,000
| +2% | +$137K | 0.11% | 90 |
|
|
2022
Q3 | $7.17M | Sell |
16,676,000
-424,000
| -2% | -$417K | 0.12% | 84 |
|
|
2022
Q2 | $13.3K | Hold |
17,100,000
| – | – | 0.23% | 73 |
|
|
2022
Q1 | $22.1M | Buy |
17,100,000
+7,434,244
| +77% | +$6.85M | 0.43% | 54 |
|
|
2021
Q4 | $12.3M | Sell |
9,665,756
-6,734,244
| -41% | -$12M | 0.2% | 89 |
|
|
2021
Q3 | $35.8M | Buy |
16,400,000
+5,352,000
| +48% | +$14.6M | 0.61% | 45 |
|
|
2021
Q2 | $41.4M | Buy |
11,048,000
+348,000
| +3% | +$1.21M | 0.74% | 35 |
|
|
2021
Q1 | $34.9M | Buy |
10,700,000
+1,108,000
| +12% | +$3.97M | 0.8% | 40 |
|
|
2020
Q4 | $32.7M | Buy |
9,592,000
+2,020,000
| +27% | +$8.31M | 1.11% | 29 |
|
|
2020
Q3 | $30.9M | Buy |
+7,572,000
| New | +$28.8M | 1.12% | 31 |
|
|
2019
Q2 | – | Sell |
-1,928,000
| Closed | -$20.6M | – | 84 |
|
|
2019
Q1 | $20.6M | Buy |
1,928,000
+428,000
| +29% | +$4.58M | 1.13% | 28 |
|
|
2018
Q4 | $13.1M | Buy |
+1,500,000
| New | +$19.1M | 0.99% | 23 |
|
|
2015
Q3 | – | Sell |
-4,436,000
| Closed | -$30.3M | – | 44 |
|
|
2015
Q2 | $30.3M | Buy |
4,436,000
+1,736,000
| +64% | +$11M | 10.9% | 2 |
|
|
2015
Q1 | $16.4M | Buy |
2,700,000
+648,000
| +32% | +$4.31M | 7.26% | 4 |
|
|
2014
Q4 | $14.2M | Buy |
+2,052,000
| New | +$15.1M | 6.83% | 1 |
|
Armistice Capital's SPPI Position: Q3 2023 in Review
Armistice Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 20,000,000 shares — an estimated $19.2M sold.
Armistice Capital first reported a position in SPPI in Q4 2014 and held it in 17 quarters. The position peaked at $41.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Armistice Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Armistice Capital sold 20,000,000 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $19.2M.
- Armistice Capital first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 17 quarters.
- Armistice Capital's Spectrum Pharmaceuticals Inc position peaked at $41.4M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.